Endotoxin-induced local inflammation and hyperalgesia in rats and mice: A new model for inflammatory pain

Pain

Volumn 66, Issue 2-3, 1996, Pages 373-379

  Kanaan, Salim A ^a   Saadé, Nayef E ^a,b   Haddad, John J ^a   Abdelnoor, Alexander M ^b   Atweh, Samir F ^a   Jabbur, Suhayl J ^a   Safieh Garabedian, Bared ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b Department of Human Morphology ^*  (Lebanon)

Author keywords

Endotoxin; Hyperalgesial; Lipopolysaccharide; Nociception; Pain tests; Peripheral inflammation

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; ETIOLOGY; HYPERALGESIA; INFLAMMATION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; RAT;

EID: 0030220692     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(96)03068-0     Document Type: Article

References (26)

1. Beasley D., Schwartz J.H., Brenner B.M. Interleukin-1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cell. J. Clin. Invests. 87:1991;602-608.
2. Bertok L. Effect of sulfhydryl compound on the lead acetate-induced endotoxin hypersensitivity of rats. J. Bacteriol. 95:1968;1974-1975.
3. Colpaert F.C., Meert T., De Witte P., Schmitt P. Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat. Life Sci. 31:1982;67-75.
4. De Castro Costa M., De Sutter P., Gybels J., Van Hees J. Adjuvant-induced arthritis in rats: a possible animal model of chronic pain. Pain. 10:1981;173-185.
5. Decker K. Biologically active products of stimulated liver macrophages (kupffer cells). Eur. J. Biochem. 192:1990;245-261.
6. Dinarello C.A. Biology of interleukin-1. FASEB J. 2:1988;108-115.
7. Dray A., Bevan S. Inflammation and hyperalgesia highlighting the team effort. Trends Pharmacol. Sci. 14:1993;287-290.
8. Ferreira S.H., Lorenzetti B.B., Bristow A.F., Poole S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature. 334:1988;698-700.
9. Ferreira S.H., Lorenzetti B.B., Poole S. Bradykinin initiates cytokine-induced inflammatory hyperalgesia. Br. J. Pharmacol. 110:1993;1227-1231.
10. Follenfant R.L., Nakamura-Craig M., Henderson B., Higgs G.A. Inhibition by neuropeptides of interleukin-1 beta-induced prostaglandin-independent hyperalgesia. Br. J. Pharmacol. 98:1989;41-43.
11. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
12. Hylden J.L.K., Nahin R.L., Traub R.J., Dubner R. Expansion of receptive fields of spinal lamina I projection neurons in rats with unilateral adjuvant-induced inflammation: the contribution of dorsal horn mechanisms. Pain. 37:1989;229-243.
13. Hylden J.L.K., Noguchi K., Ruda M.A. Neonatal capsaicin treatment attenuates spinal fos activation and dynorphin gene expression following peripheral tissue inflammation and hyperalgesia. J. Neurosci. 12:1992;1716-1725.
14. Iadarola M.J., Brady I.S., Draisei G., Dubner R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation stimulates specificity, behavioral parameters and opioid receptor binding. Pain. 35:1988;313-326.
15. Kent S., Bluthe R.M., Kelley K.W., Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 13:1992;24-28.
16. Maier S.F., Wiertelak E.P., Goehler L., Martin D., Watkins L.R. Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res. 623:1993;321-325.
17. 2 release. Eur. J. Pharmacol. 166:1989;131-137.
18. Randall L.O., Sellitto J.J. A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. Ther. 111:1957;409-419.
19. Rietschel E., Kirikae T., Schade U., Mamat U., Schmidt G., Loppnow H., Ulmer A., Zahringer U., Seydel U., Padova F., Schrier M., Brade H. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8:1994;217-225.
20. Rogoff T.M., Lipski P.E. Role of the Kupffer cells in local and systemic immune responses. Gastroenterology. 80:1981;854-860.
21. Safieh-Garabedian B., Kanaan S.A., Haddad J., Malik S., Abdelnoor A., Saadé N.E., Jabbur S.J. Hyperalgesia produced by endotoxin (ET) injections; a new model for localized inflammatory pain in rats and mice. Soc. Neurosci. Abstr. 21:1995;643.
22. Sin Y.M., Chio S.L. Effect of carrageenan-induced acute inflammation on cortisone levels in mice. Agents Actions. 29:1990;196-200.
23. Watkins L.R., Wiertelak E.P., Goehler L.E., Mooney-Heiberger K., Martinez J., Furness L., Smith K.P., Maier S.F. Neurocircuitry of illness-induced hyperalgesia. Brain Res. 639:1994;283-299.
24. Watkins L.R., Wiertelak E.P., Goehler L.E., Smith K.P., Martin D., Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Res. 654:1994;15-26.
25. Wiertelak E.P., Smith K.P., Furness L., Mooney-Heiberger K., Mayr T., Maier S.F., Watkins L.R. Acute and conditioned hyperalgesia responses to illness. Pain. 56:1994;227-234.
26. Zimmerman M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.